Mission Pharmacal Company v. MainPointe Pharmaceuticals, LLC
Plaintiff: Mission Pharmacal Company
Defendant: MainPointe Pharmaceuticals, LLC
Case Number: 1:2022cv04226
Filed: May 23, 2022
Court: US District Court for the Southern District of New York
Office: Foley Square Office
Presiding Judge: Denise L Cote
Nature of Suit: Contract: Other
Cause of Action: 28 U.S.C. § 1332 Diversity Action
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on November 16, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 14, 2022 Opinion or Order Filing 22 ORDER granting #21 Motion for John Andrew Tucker to Appear Pro Hac Vice (HEREBY ORDERED by Judge Denise L. Cote)(Text Only Order) (jwh)
July 14, 2022 >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #21 MOTION for John Andrew Tucker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-26405895. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (sgz)
July 13, 2022 Filing 21 MOTION for John Andrew Tucker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-26405895. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Mission Pharmacal Company. (Attachments: #1 Affidavit In Support of Motion for Admission Pro Hac Vice (Including Annexed Certificate of Good Standing), #2 Text of Proposed Order Proposed Order for Admission Pro Hac Vice).(Tucker, John)
July 11, 2022 Opinion or Order Filing 20 ORDER terminating #16 Letter Motion for Extension of Time to Answer re #16 SECOND LETTER MOTION for Extension of Time to File Answer or move until August 2, 2022 addressed to Judge Denise L. Cote from Ronald J. Rosenberg dated July 8, 2022. The conference shall proceed as scheduled on 7/28/22. The answer is due 7/23/22. There shall be no further adjournment. (Signed by Judge Denise L. Cote on 7/11/2022) (vfr)
July 11, 2022 Set/Reset Deadlines: MainPointe Pharmaceuticals, LLC answer due 7/23/2022. (vfr)
July 8, 2022 Filing 19 LETTER addressed to Judge Denise L. Cote from Jonathan H. Friedman dated July 8, 2022 re: Defendant's Second Letter Motion #16 . Document filed by Mission Pharmacal Company..(Friedman, Jonathan)
July 8, 2022 Filing 18 NOTICE OF APPEARANCE by Lesley Reardon on behalf of MainPointe Pharmaceuticals, LLC..(Reardon, Lesley)
July 8, 2022 Filing 17 NOTICE OF APPEARANCE by Ronald Rosenberg on behalf of MainPointe Pharmaceuticals, LLC..(Rosenberg, Ronald)
July 8, 2022 Filing 16 SECOND LETTER MOTION for Extension of Time to File Answer or move until August 2, 2022 addressed to Judge Denise L. Cote from Ronald J. Rosenberg dated July 8, 2022. Document filed by MainPointe Pharmaceuticals, LLC..(Rosenberg, Ronald)
July 1, 2022 Opinion or Order Filing 15 ORDER: IT IS HEREBY ORDERED that the initial conference scheduled for July 28 is moved to 11:00 AM on that same date. Please refer to the Order issued on May 25 for all other information regarding the conference. SO ORDERED. Initial Conference set for 7/28/2022 at 11:00 AM before Judge Denise L. Cote. (Signed by Judge Denise L. Cote on 7/1/2022) (vfr)
June 22, 2022 Filing 14 NOTICE of Compliance with Court's Notice of Initial Pretrial Conference. Document filed by Mission Pharmacal Company. (Attachments: #1 Exhibit June 14 Email to MainPointe Pharmaceuticals, LLC, #2 Exhibit June 17 Email to Counsel for MainPointe Pharmaceuticals, LLC).(Friedman, Jonathan)
June 17, 2022 Opinion or Order Filing 13 ORDER granting #11 Letter Motion for Extension of Time; granting #12 Letter Motion for Extension of Time. Granted. (Signed by Judge Denise L. Cote on 6/17/2022) (tg)
June 17, 2022 Filing 12 FIRST LETTER MOTION for Extension of Time to move or answer until July 12, 2022 (Correcting Docket Entry 11) addressed to Judge Denise L. Cote from Ronald J. Rosenberg dated June 17, 2022. Document filed by MainPointe Pharmaceuticals, LLC..(Rosenberg, Ronald)
June 17, 2022 Filing 11 FIRST LETTER MOTION for Extension of Time to move or answer until June 12, 2022 addressed to Judge Denise L. Cote from Ronald J Rosenberg dated June 17, 2022. Document filed by MainPointe Pharmaceuticals, LLC..(Rosenberg, Ronald)
June 17, 2022 Set/Reset Deadlines: MainPointe Pharmaceuticals, LLC answer due 7/12/2022. (tg)
June 10, 2022 Filing 10 AFFIDAVIT OF SERVICE. All Defendants. Service was accepted by Doug Morris, Chief Financial Officer. Document filed by Mission Pharmacal Company..(Friedman, Jonathan)
May 25, 2022 Filing 9 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Mission Pharmacal Company..(Friedman, Jonathan)
May 25, 2022 Filing 8 NOTICE OF APPEARANCE by Jonathan Hale Friedman on behalf of Mission Pharmacal Company..(Friedman, Jonathan)
May 25, 2022 Opinion or Order Filing 7 NOTICE OF INITIAL PRETRIAL CONFERENCE: Initial Conference by telephone set for 7/28/2022 at 3:00 PM before Judge Denise L. Cote. The parties shall use the following dial-in credentials for the conference. Dial-in: 888-363-4749 Access code: 4324948. The parties shall use a landline if one is available. SO ORDERED. (Signed by Judge Denise L. Cote on 5/25/2022) (vfr)
May 25, 2022 Filing 6 ELECTRONIC SUMMONS ISSUED as to MainPointe Pharmaceuticals, LLC..(gp)
May 23, 2022 Filing 5 REQUEST FOR ISSUANCE OF SUMMONS as to MainPointe Pharmaceuticals, LLC, re: #1 Complaint. Document filed by Mission Pharmacal Company..(Friedman, Jonathan)
May 23, 2022 Filing 4 SEALED DOCUMENT placed in vault..(jus)
May 23, 2022 Filing 3 DOCUMENTS TO BE SEALED (Signed by Judge Loretta A. Preska on 5/20/2022) (pc)
May 23, 2022 Filing 2 CIVIL COVER SHEET filed..(pc) (gp).
May 23, 2022 Filing 1 COMPLAINT against MainPointe Pharmaceuticals, LLC. (Filing Fee $ 402.00, Receipt Number 442)Document filed by Mission Pharmacal Company..(pc) (Additional attachment(s) added on 5/25/2022: #1 Exhibit A) (gp).
May 23, 2022 Magistrate Judge Robert W. Lehrburger is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc)
May 23, 2022 Case Designated ECF. (pc)
May 23, 2022 Opinion or Order ORDER REDACTING PLEADING FILED IN 22-MC-143. Document filed by Mission Pharmacal Company..(pc)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System

Search for this case: Mission Pharmacal Company v. MainPointe Pharmaceuticals, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Mission Pharmacal Company
Represented By: Jonathan Hale Friedman
Represented By: John A. Tucker
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MainPointe Pharmaceuticals, LLC
Represented By: Ronald Rosenberg
Represented By: Lesley Reardon
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?